BAYN

Bayer AG (BAYN)

Market Open
18 Jun, 09:31
27. 08
+0.19
+0.71%
- Market Cap
- P/E Ratio
0.44% Div Yield
47,348 Volume
0 Eps
26.89
Previous Close
Day Range
26.88 27.18
Year Range
18.43 31.01
Earnings results expected in 49 days

Summary

BAYN trading today higher at €27.08, an increase of 0.71% from yesterday's close, completing a monthly increase of 14.33% or €3.39. Over the past 12 months, BAYN stock gained 40.82%.
BAYN is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Aug 06, 2025.
The stock of the company had never split.
The company's stock is traded on 13 different exchanges and in various currencies, with the primary listing on XWBO (EUR).
Want to track BAYN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

BAYN Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.

Bayer AG Dividends

BAYN
BAYN 29 Apr 2024
Other
€0.11 Per Share
BAYN
BAYN 2 May 2023
Other
€2.4 Per Share
BAYN
BAYN 2 May 2022
Other
€2 Per Share
BAYN
BAYN 28 Apr 2021
Other
€2 Per Share
BAYN
BAYN 29 Apr 2020
Other
€2.8 Per Share

Bayer AG Earnings

6 Aug 2025 (49 Days) Date
-
Cons. EPS
-
EPS
13 May 2025 Date
-
Cons. EPS
-
EPS
5 Mar 2025 Date
-
Cons. EPS
-
EPS
12 Nov 2024 Date
-
Cons. EPS
-
EPS
6 Aug 2024 Date
0.88
Cons. EPS
0.94
EPS
BAYN
BAYN 29 Apr 2024
Other
€0.11 Per Share
BAYN
BAYN 2 May 2023
Other
€2.4 Per Share
BAYN
BAYN 2 May 2022
Other
€2 Per Share
BAYN
BAYN 28 Apr 2021
Other
€2 Per Share
BAYN
BAYN 29 Apr 2020
Other
€2.8 Per Share
6 Aug 2025 (49 Days) Date
-
Cons. EPS
-
EPS
13 May 2025 Date
-
Cons. EPS
-
EPS
5 Mar 2025 Date
-
Cons. EPS
-
EPS
12 Nov 2024 Date
-
Cons. EPS
-
EPS
6 Aug 2024 Date
0.88
Cons. EPS
0.94
EPS

Bayer AG (BAYN) FAQ

What is the stock price today?

The current price is €27.08.

On which exchange is it traded?

Bayer AG is listed on XWBO.

What is its stock symbol?

The ticker symbol is BAYN.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Aug 06, 2025.

Has Bayer AG ever had a stock split?

No, there has never been a stock split.

Bayer AG Profile

Drug Manufacturers - General Industry
Healthcare Sector
Mr. William N. Anderson CEO
XSTU Exchange
DE000BAY0017 ISIN
Germany Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Bayer Aktiengesellschaft is a global life science company with a diversified portfolio that spans across Pharmaceuticals, Consumer Health, and Crop Science segments. Having been founded in 1863, Bayer has solidified its presence worldwide, engaging in activities that range from the development of prescription medicines and consumer health products to innovations in agriculture. The company is committed to leveraging scientific advancements to address some of the most pressing challenges in healthcare and agriculture. Bayer’s collaborations with institutions such as Acuitas Therapeutics, Inc., Peking University, the Swiss Tropical and Public Health Institute, bit.bio Ltd., Hologic, Inc., Twist Bioscience Corporation, and CrossBay Medical Inc., underscore its dedication to pushing the boundaries of what is possible in science. With a strong distribution network that includes wholesalers, pharmacies, supermarkets, online retailers, and hospitals, as well as direct connections to farmers, Bayer ensures its products and solutions are accessible globally. The company’s headquarters are located in Leverkusen, Germany, reflecting its roots and long-standing history.

Products and Services

  • Pharmaceuticals

    This segment focuses on prescription products in cardiology, women's health care, specialty therapeutics in oncology, hematology, and ophthalmology. Bayer also provides diagnostic imaging equipment and digital solutions, contrast agents, as well as pioneering in cell and gene therapy. Through collaboration with entities like Acuitas Therapeutics, Inc. and Peking University, Bayer advances in gene editing and pharmaceutical research.

  • Consumer Health

    Under the Consumer Health segment, Bayer markets a wide range of nonprescription over-the-counter medicines targeting self-medication and self-care needs. These include nutritional supplements, allergy relief, cough and cold solutions, dermatology products, pain and cardiovascular risk prevention medications, and digestive health products. Bayer’s approach to consumer health emphasizes safety and efficacy, providing reliable options for daily health and wellness.

  • Crop Science

    The Crop Science segment contributes to agriculture through seeds, plant traits enhancements, chemical and biological crop protection products, digital agriculture solutions, and extensive customer service. Bayer focuses on increased agricultural productivity and sustainability, offering solutions like seed breeding, propagation, and production/processing, including seed dressing. Collaborations with institutions such as the Swiss Tropical and Public Health Institute for the development of emodepside showcase Bayer's commitment to addressing global agricultural challenges.

  • Collaborative Research and Development

    Bayer places a strong emphasis on collaboration, partnering with leading universities, research institutes, and companies to enhance its product pipeline and explore new therapeutic areas. These partnerships, including those with Hologic, Inc. in diagnostic imaging for breast cancer detection, Twist Bioscience Corporation in antibody-based pharmaceuticals research, and others, demonstrate Bayer’s commitment to innovation and advancing health care and agricultural practices.

Contact Information

Address: Kaiser-Wilhelm-Allee 1
Phone: 49 214 30 1